Luteolin downregulates the expression of TLR4, MyD88, and NF-κB in a dose-dependent manner to inhibit NLRP3 inflammasome activation, consequently diminishing myocardial infarct size and enhancing left ventricular function (145). This evidence concerns the gene NFKB1 and myocardial infarction.